Cargando…

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies

Aggregation of the pre-synaptic protein, α-synuclein (α-syn), is the key etiological factor in Parkinson's disease (PD) and other alpha-synucleinopathies, such as multiple system atrophy (MSA) and Dementia with Lewy bodies (DLB). Various triggers for pathological α-syn aggregation have been elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rcom-H'cheo-Gauthier, Alexandre N., Osborne, Samantha L., Meedeniya, Adrian C. B., Pountney, Dean L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167751/
https://www.ncbi.nlm.nih.gov/pubmed/28066161
http://dx.doi.org/10.3389/fnins.2016.00570
_version_ 1782483208951037952
author Rcom-H'cheo-Gauthier, Alexandre N.
Osborne, Samantha L.
Meedeniya, Adrian C. B.
Pountney, Dean L.
author_facet Rcom-H'cheo-Gauthier, Alexandre N.
Osborne, Samantha L.
Meedeniya, Adrian C. B.
Pountney, Dean L.
author_sort Rcom-H'cheo-Gauthier, Alexandre N.
collection PubMed
description Aggregation of the pre-synaptic protein, α-synuclein (α-syn), is the key etiological factor in Parkinson's disease (PD) and other alpha-synucleinopathies, such as multiple system atrophy (MSA) and Dementia with Lewy bodies (DLB). Various triggers for pathological α-syn aggregation have been elucidated, including post-translational modifications, oxidative stress, and binding of metal ions, such as calcium. Raised neuronal calcium levels in PD may occur due to mitochondrial dysfunction and/or may relate to calcium channel dysregulation or the reduced expression of the neuronal calcium buffering protein, calbindin-D28k. Recent results on human tissue and a mouse oxidative stress model show that neuronal calbindin-D28k expression excludes α-syn inclusion bodies. Previously, cell culture model studies have shown that transient increases of intracellular free Ca(II), such as by opening of the voltage-gated plasma calcium channels, could induce cytoplasmic aggregates of α-syn. Raised intracellular free calcium and oxidative stress also act cooperatively to promote α-syn aggregation. The association between raised neuronal calcium, α-syn aggregation, oxidative stress, and neurotoxicity is reviewed in the context of neurodegenerative α-syn disease and potential mechanism-based therapies.
format Online
Article
Text
id pubmed-5167751
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51677512017-01-06 Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies Rcom-H'cheo-Gauthier, Alexandre N. Osborne, Samantha L. Meedeniya, Adrian C. B. Pountney, Dean L. Front Neurosci Neuroscience Aggregation of the pre-synaptic protein, α-synuclein (α-syn), is the key etiological factor in Parkinson's disease (PD) and other alpha-synucleinopathies, such as multiple system atrophy (MSA) and Dementia with Lewy bodies (DLB). Various triggers for pathological α-syn aggregation have been elucidated, including post-translational modifications, oxidative stress, and binding of metal ions, such as calcium. Raised neuronal calcium levels in PD may occur due to mitochondrial dysfunction and/or may relate to calcium channel dysregulation or the reduced expression of the neuronal calcium buffering protein, calbindin-D28k. Recent results on human tissue and a mouse oxidative stress model show that neuronal calbindin-D28k expression excludes α-syn inclusion bodies. Previously, cell culture model studies have shown that transient increases of intracellular free Ca(II), such as by opening of the voltage-gated plasma calcium channels, could induce cytoplasmic aggregates of α-syn. Raised intracellular free calcium and oxidative stress also act cooperatively to promote α-syn aggregation. The association between raised neuronal calcium, α-syn aggregation, oxidative stress, and neurotoxicity is reviewed in the context of neurodegenerative α-syn disease and potential mechanism-based therapies. Frontiers Media S.A. 2016-12-20 /pmc/articles/PMC5167751/ /pubmed/28066161 http://dx.doi.org/10.3389/fnins.2016.00570 Text en Copyright © 2016 Rcom-H'cheo-Gauthier, Osborne, Meedeniya and Pountney. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Rcom-H'cheo-Gauthier, Alexandre N.
Osborne, Samantha L.
Meedeniya, Adrian C. B.
Pountney, Dean L.
Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title_full Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title_fullStr Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title_full_unstemmed Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title_short Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
title_sort calcium: alpha-synuclein interactions in alpha-synucleinopathies
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167751/
https://www.ncbi.nlm.nih.gov/pubmed/28066161
http://dx.doi.org/10.3389/fnins.2016.00570
work_keys_str_mv AT rcomhcheogauthieralexandren calciumalphasynucleininteractionsinalphasynucleinopathies
AT osbornesamanthal calciumalphasynucleininteractionsinalphasynucleinopathies
AT meedeniyaadriancb calciumalphasynucleininteractionsinalphasynucleinopathies
AT pountneydeanl calciumalphasynucleininteractionsinalphasynucleinopathies